Global Oxygenators for Pediatric and Infant Use Market Strategic Research Report

Scope of the Report

The global Oxygenators for Pediatric and Infant Use market size is predicted to grow from US$ 262 million in 2025 to US$ 445 million in 2032; it is expected to grow at a CAGR of 7.9% from 2026 to 2032.

In 2025, global sales of Oxygenators for Pediatric and Infant Use reached 1.45 million units, with an average selling price of $185 per unit. Total global production capacity stands at approximately 1.8 million units per year, and the industry's average gross profit margin is around 48%; within the downstream consumption mix, extracorporeal circulation for cardiac surgery accounts for 55%. These oxygenators are blood-gas exchange devices specifically designed for extracorporeal circulation, cardiac surgery, ECMO support, and intensive care scenarios involving newborns, infants, and children. Their core function is to replace or assist lung function in oxygenation and carbon dioxide removal during extracorporeal circulation, while minimizing priming volume, blood trauma, inflammatory responses, and coagulation risks. Typically composed of hollow fiber membranes, blood flow paths, gas exchange chambers, heat exchange modules, housings, ports, and filtration structures, these products demand high standards for biocompatibility, low flow resistance, minimal hemolysis, and low-volume design.

Key upstream raw materials include polypropylene hollow fiber membranes, polycarbonate housings, medical-grade silicone, polyurethane sealing materials, heparin coating materials, and precision injection-molded parts; downstream distribution targets children's hospitals, cardiac surgery departments in general hospitals, ICUs, ECMO centers, and distributors of extracorporeal circulation consumables. Future development trends focus on miniaturization, reduced priming volumes, optimized anticoagulant coatings, suitability for long-term ECMO support, and upgrades to high-safety, single-use consumables. Demand growth is driven primarily by the rising volume of congenital heart disease surgeries, increased ECMO penetration rates among pediatric patients, and the shift toward high-end single-use consumables; business opportunities lie in highly biocompatible membrane materials, low-thrombosis-risk coatings, and the development of specialized products tailored for low-birth-weight newborns.

Global key Oxygenators for Pediatric and Infant Use players cover LivaNova, Medtronic, Terumo, Getinge, Eurosets, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oxygenators for Pediatric and Infant Use market?

What factors are driving Oxygenators for Pediatric and Infant Use market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oxygenators for Pediatric and Infant Use market opportunities vary by end market size?

How does Oxygenators for Pediatric and Infant Use break out by Type, by Application?

This report presents a comprehensive overview of the global Oxygenators for Pediatric and Infant Use market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Hollow-fiber Membrane Oxygenator
• Flat-sheet Membrane Oxygenator
• Miniature Integrated Oxygenator

Segment by Material

• Polypropylene (PP) Film
• PMP Film
• Others

Segment by Suitable Weight

• Suitable Weight: <3kg
• Suitable Weight: 3–10kg
• Suitable Weight: 10–25kg
• Suitable Weight: >25kg

Segment by Application

• Children
• Newborns

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Oxygenators for Pediatric and Infant Use market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Children, Newborns evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact